Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051805 · ClinicalTrials.gov registry record · NA
Promoting Adherence to Anti-HIV Drug Regimens
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT00051805 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 119 participants.
The verdict
NCT00051805, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
One of the main causes of treatment failure in HIV infected individuals is lack of adherence to complicated drug regimens. The purpose of this study is to evaluate the effectiveness of a behavioral intervention program designed to improve adherence to anti-HIV drug regimens. Participants in this study will be recruited from the University of Alabama at Birmingham (UAB) Outpatient HIV Clinic.
Interventions
- BEHAVIORAL Promotion of adherence to ARV medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00051805
The ClinicalTrials.gov registry entry for NCT00051805 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Promotion of adherence to ARV medications is the first listed.
NCT00051805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00051805 about?
NCT00051805 is a clinical study titled "Promoting Adherence to Anti-HIV Drug Regimens". One of the main causes of treatment failure in HIV infected individuals is lack of adherence to complicated drug regimens. The purpose of this study is to evaluate the effectiveness of a behavioral intervention program designed to improve adherence to anti-HIV drug regimens. Participants in this stu...
What is the current status of trial NCT00051805?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2002-08. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00051805?
The interventions under investigation include: Promotion of adherence to ARV medications (BEHAVIORAL).
Who is sponsoring clinical trial NCT00051805?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.